ARCHIVES

Prevention & Control Study Section In DRG Requested By NCI

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Biopsy System Effective In Removing Benign Breast Masses, Study Finds

May 28, 2004

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

October 26, 2007

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984